Novartis Cash from Investing (TTM) Analysis

Novartis AG (NVS)

97.84 +2.72 (+2.86%) USD | NYSE | Apr 23, 12:50

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2003. Upgrade now.

Date	Value
December 31, 2023	5.596B
September 30, 2023	5.889B
June 30, 2023	13.30B
March 31, 2023	2.724B
December 31, 2022	1.468B
September 30, 2022	7.498B
June 30, 2022	1.068B
March 31, 2022	12.79B
December 31, 2021	4.208B
September 30, 2021	-926.00M
June 30, 2021	-1.739B
March 31, 2021	-2.261B
December 31, 2020	-13.18B
September 30, 2020	-12.29B
June 30, 2020	-13.65B
March 31, 2020	-13.70B
December 31, 2019	-2.226B
September 30, 2019	-7.479B
June 30, 2019	-4.967B
March 31, 2019	-168.00M
December 31, 2018	-5.591B
September 30, 2018	-1.652B
June 30, 2018	-1.451B
March 31, 2018	-6.113B
December 31, 2017	-3.119B

Date	Value
September 30, 2017	-3.196B
June 30, 2017	-3.263B
March 31, 2017	-3.77B
December 31, 2016	-3.441B
September 30, 2016	-4.058B
June 30, 2016	-4.059B
March 31, 2016	-4.999B
December 31, 2015	-10.78B
September 30, 2015	-10.01B
June 30, 2015	-9.206B
March 31, 2015	-8.499B
December 31, 2014	881.00M
September 30, 2014	-855.00M
June 30, 2014	-1.662B
March 31, 2014	-1.225B
December 31, 2013	-3.352B
September 30, 2013	-3.233B
June 30, 2013	-4.451B
March 31, 2013	-4.534B
December 31, 2012	-5.675B
September 30, 2012	-3.963B
June 30, 2012	-2.561B
March 31, 2012	-1.728B
December 31, 2011	-792.00M
September 30, 2011	-555.00M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-13.70B

Minimum

Mar 2020

13.30B

Maximum

Jun 2023

-940.58M

Average

-926.00M

Median

Sep 2021

Cash from Investing (TTM) Benchmarks